Inventor · disambiguated record
David A. Born
Also filed as: BORN DAVID · BORN DAVID A
5 granted patents·11 pending applications·36 citations·filing 2020–2025
80Inventor score
Files withBEAM THERAPEUTICS INC16
Top patents by PatentIndex Score
16 records- 0196US11344609B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted May 31, 2022·6 cites·34 claims
- 0296US11142760B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted Oct 12, 2021·14 cites·30 claims
- 0395US11752202B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·3 cites·28 claims
- 0492US11155803B2Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·13 cites·30 claims
- 0581US12016908B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 0676US2024132867A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0770US2022235347A1Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0869US2024327813A1Crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0960US2024167008A1Novel crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1055US2022170027A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1153US2023101597A1Compositions and methods for treating alpha-1 antitrypsin deficiencyBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1252US2022098593A1Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1352US2025236852A1Large serine recombinases, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1452US2022136012A1Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1551US2022127594A1Compositions and methods for treating glycogen storage disease type 1aBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1647US2023140953A1Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Born files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →